BiochemistrybioRxiv
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir (PF-07321332)
S. Ullrich, K. B. Ekanayake, G. Otting, C. Nitsche
This study shows that nirmatrelvir remains effective against Mpro variants from current SARS-CoV-2 lineages.
DOI 10.1016/j.bmcl.2022.128629